Skip to main content

1 Result(s)

within Sara Majocchi Remove this filter English Remove this filter

and

  1. Article

    Open Access

    Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers

    T-cell retargeting to eliminate CEACAM5-expressing cancer cells via CEACAM5xCD3 bispecific antibodies (BsAbs) showed limited clinical activity so far, mostly due to insufficient T-cell activation, dose-limitin...

    Anja Seckinger, Sara Majocchi, Valéry Moine… in Journal of Hematology & Oncology (2023)

    Download PDF (7748 KB) View Article